➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for PQR309

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug PQR309?

PQR309 is an investigational drug.

There have been 9 clinical trials for PQR309. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2018.

The most common disease conditions in clinical trials are Lymphoma, Lymphoma, Non-Hodgkin, and Glioblastoma. The leading clinical trial sponsors are PIQUR Therapeutics AG, University Hospital, Basel, Switzerland, and Roswell Park Cancer Institute.

There are ten US patents protecting this investigational drug and eighty-seven international patents.

Recent Clinical Trials for PQR309
Study Evaluating Safety and Efficacy of Bimiralisib in Patients With Head and Neck Squameous Cell CarcinomaPIQUR Therapeutics AGPhase 2
PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System LymphomaPIQUR Therapeutics AGPhase 2
Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma PatientsCharite University, Berlin, GermanyPhase 2

See all PQR309 clinical trials

Clinical Trial Summary for PQR309

Top disease conditions for PQR309
Top clinical trial sponsors for PQR309

See all PQR309 clinical trials

US Patents for PQR309

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PQR309   Get Started Free Manufacturing process for triazine, pyrimidine and pyridine derivatives UNIVERSITAET BASEL (Basel, CH) PIQUR THERAPEUTICS AG (Basel, CH)   Get Started Free
PQR309   Get Started Free Uses of indolinone compounds Oncternal Therapeutics, Inc. (San Diego, CA)   Get Started Free
PQR309   Get Started Free Compositions of CXCR4 inhibitors and methods of preparation and use X4 PHARMACEUTICALS, INC. (Cambridge, MA)   Get Started Free
PQR309   Get Started Free Crystalline forms Array Biopharma Inc. (Boulder, CO)   Get Started Free
PQR309   Get Started Free Compounds for treating cancer BICYCLERD LIMITED (Cambridge, GB)   Get Started Free
PQR309   Get Started Free Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines PIQUR THERAPEUTICS AG (Basel, CH) UNIVERSITAT BASEL (Basel, CH)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for PQR309

Drugname Country Document Number Estimated Expiration Related US Patent
PQR309 Australia AU2015250994 2034-04-22   Get Started Free
PQR309 Brazil BR112016023811 2034-04-22   Get Started Free
PQR309 Canada CA2944697 2034-04-22   Get Started Free
PQR309 China CN106458968 2034-04-22   Get Started Free
PQR309 European Patent Office EP3134388 2034-04-22   Get Started Free
PQR309 Spain ES2713452 2034-04-22   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.